Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Registration of Stryker Rejuvenate Hip Cases Required Following Settlement November 17, 2014 Austin Kirk Add Your Comments Following a recent global Stryker Rejuvenate settlement, which is intended to resolve thousands of cases over the recalled hip implant, a federal judge has ordered the registration of all potential claims, regardless of whether they have yet been filed. There are currently about 5,000 Stryker Rejuvenate and ABG II hip lawsuits filed in state and federal courts nationwide, each involving problems experienced after receiving the modular implants, often resulting in the need for revision surgery to remove the defective implant. There were more than 20,000 of Rejuvenate and ABG II implants sold before a Stryker recall was issued in July 2012, when it was determined that the modular neck stem components pose an unreasonable risk of fretting, corroding and ultimately failing as the metal parts rub against each other. Stay Up-to-Date About hip replacement lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new hip replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Hip Replacement Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new hip replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More In a Pretrial Order (PDF) issued last week, U.S. District Judge Donovan Frank indicating that all lawyers involved in the litigation must register their Stryker Rejuvenate hip cases, including both filed and un-filed lawsuits, as well as claims for individuals who have not yet required revision surgery. Judge Frank is presiding over all federal cases involving the Stryker Rejuvenate or ABG II implants, which have been centralized as part of a multidistrict litigation (MDL) in the U.S. District Court for the District of Missouri. However, the order was issued in cooperation with the litigation in New Jersey state court as well as other state courts nationwide. Following a status conference before Judge Frank, the order was issued to “effectuate the provisions of the private Settlement Agreement,” requiring that all filed and unfiled claims relating to the ABG II Modular Neck Hip Stem or Rejuvenate Modular Neck Hip Stem be identified. The settlement is expected to result in a base payment of $300,000 for each Stryker Rejuvenate or ABG II plaintiff who underwent revision surgery on or before November 2, and otherwise qualifies for the settlement. However, there will be several factors that may reduce the base award, including the plaintiff’s age, prior hip revision surgeries and other related health conditions. In addition, individuals who suffered catastrophic injuries will be able to pursue additional compensation under the settlement if they meet several eligibility requirements for “enhancements.” “While registration is mandatory pursuant to this Court order, uploading the Registration Declaration and Registration List on the claim processor’s website in no way signifies a claimants commitment or intent to enroll in the settlement program,” wrote Judge Frank in the order. The Stryker Rejuvenate case registration opened on November 14, and lawyers are required to submit complete lists by December 14. For each case, lawyers must provide certain information about the client, as well as designate a Primary Law Firm and appropriate contact information. Following registration, claimants who wish to accept the terms of the settlement must enroll in the program between January 15, 2015 and March 2, 2015. Unlike traditional hip implants, which feature a single femoral component, the Stryker Rejuvenate and ABG II implants featured a modular neck-stem, with two pieces that fit inside of each other to allow the surgeon to customize the length of the femoral component based on the patient. As the chromium-cobalt components rubbed against each other during normal daily activities, the implant design has been found to release microscopic metal debris, which can lead to failure of the implant. Although the settlement only applies to cases that have required revision surgery by November 2, given the high failure rate with Stryker Rejuvenate hips, it is ultimately expected that new cases will continue to be filed over the next few years, and it is possible that additional settlements will be reached. Judge Frank has indicated that after submitting the Complete Registration Declarations and lists, lawyers are obligated to serve an updated Report if there are any changes in the status of the cases, including if cases are subsequently filed or if the hip patients end up requiring revision surgery in the future. Tags: Hip Replacement System, Stryker, Stryker ABG II, Stryker Rejuvenate More Hip Replacements Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: today) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025) Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: yesterday) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025) Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 2 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: today) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: yesterday) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)
Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 2 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)